EUVIMEDEUVIMED entdecken
Open Access

Intrinsically disordered protein coating for oral delivery of peptide drugs

Max Ney, Parul Sirohi, Yulia Shmidov, Anurag Singh, Gable Wadsworth, Xinghai Li, James Zheng, Erica Peng, Lixin Fan, Tharun Selvam Mahendran, Sonal Deshpande, Navya Tripathi und 5 weitere

Cell Biomaterials · 2026-05 · 100460

DOI: 10.1016/j.celbio.2026.100460 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biomaterials, 2026-05. Verfasst von Max Ney und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIH HHS, Intramural NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advancing oral delivery of peptide therapeutics requires innovative materials that overcome gastrointestinal barriers. We introduce an engineered synthetic intrinsically disordered protein (SynIDP) that self-assembles into an enteric coating, encapsulating peptide drugs to enhance gastric acid resistance and intestinal targeting. This SynIDP recapitulates the molecular design principles and phase transitions of native intrinsically disordered proteins (IDPs), enabling it to exhibit temperature-controlled condensation and pH-controlled solidification, with both transitions being reversible in response to intestinal cues. Through analysis of the kinetics of the liquid-to-solid phase transition, we achieve control over the nano-to-microscale morphology of the protein coating, optimizing drug encapsulation and protection. The coating protects peptide-based drugs for over 60 min under simulated gastric conditions, then dissolves to release the active compound. Oral delivery to obese mice results in more consistent weight loss compared with the unencapsulated drug. This modular, protein-based coating is a promising platform technology for enhancing oral peptide drug delivery and improving patient compliance.

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA.
  • Department of Physics, University at Buffalo, Buffalo, NY 14214, USA.
  • Protein-Nucleic Acid Interaction Section, Center for Structural Biology, National Cancer Institute, Frederick, MD 21702, USA.
  • Lead contact.

Förderung

  • NIGMS NIH HHS
  • NIH HHS
  • Intramural NIH HHS
  • National Institute of General Medical Sciences
  • Biological and Environmental Research
  • National Institutes of Health
  • US Department of Energy Basic Energy Sciences
  • National Cancer Institute

Zitieren

APA

Ney, M., Sirohi, P., Shmidov, Y., Singh, A., Wadsworth, G., Li, X., Zheng, J., Peng, E., Fan, L., Mahendran, T. S., Deshpande, S., Tripathi, N., Su, J. C., Milligan, J. J., Wang, Y. X., Banerjee, P. R., & Chilkoti, A. (2026). Intrinsically disordered protein coating for oral delivery of peptide drugs. Cell Biomaterials, 100460. https://doi.org/10.1016/j.celbio.2026.100460

Vancouver

Ney M, Sirohi P, Shmidov Y, Singh A, Wadsworth G, Li X, et al. Intrinsically disordered protein coating for oral delivery of peptide drugs. Cell Biomaterials. 2026:100460. doi:10.1016/j.celbio.2026.100460

BibTeX
@article{Ney2026,
  author = {Ney, Max and Sirohi, Parul and Shmidov, Yulia and Singh, Anurag and Wadsworth, Gable and Li, Xinghai and Zheng, James and Peng, Erica and Fan, Lixin and Mahendran, Tharun Selvam and Deshpande, Sonal and Tripathi, Navya and Su, Jonathan C and Milligan, Joshua James and Wang, Yun-Xing and Banerjee, Priya R and Chilkoti, Ashutosh},
  title = {Intrinsically disordered protein coating for oral delivery of peptide drugs},
  journal = {Cell Biomaterials},
  year = {2026},
  pages = {100460},
  doi = {10.1016/j.celbio.2026.100460}
}
Kostenlos starten →